144 related articles for article (PubMed ID: 27725724)
21. TALEN-induced disruption of Nanog expression results in reduced proliferation, invasiveness and migration, increased chemosensitivity and reversal of EMT in HepG2 cells.
Yu AQ; Ding Y; Li CL; Yang Y; Yan SR; Li DS
Oncol Rep; 2016 Mar; 35(3):1657-63. PubMed ID: 26676719
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a stem-like population in hepatocellular carcinoma MHCC97 cells.
Zhang N; Li R; Tao KS; Cao DY; Ti ZY; Ding R; Cai L; Zhang FQ; Dou KF
Oncol Rep; 2010 Mar; 23(3):827-31. PubMed ID: 20127026
[TBL] [Abstract][Full Text] [Related]
24. Isolation and identification of a distinct side population cancer cells in the human epidermal squamous cancer cell line A431.
Geng S; Wang Q; Wang J; Hu Z; Liu C; Qiu J; Zeng W
Arch Dermatol Res; 2011 Apr; 303(3):181-9. PubMed ID: 21240514
[TBL] [Abstract][Full Text] [Related]
25. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
26. CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells.
Lan X; Wu YZ; Wang Y; Wu FR; Zang CB; Tang C; Cao S; Li SL
Int J Mol Med; 2013 Feb; 31(2):315-24. PubMed ID: 23233126
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
[TBL] [Abstract][Full Text] [Related]
28. Characterization of side population cells isolated from the colon cancer cell line SW480.
Xiong B; Ma L; Hu X; Zhang C; Cheng Y
Int J Oncol; 2014 Sep; 45(3):1175-83. PubMed ID: 24926880
[TBL] [Abstract][Full Text] [Related]
29. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
30. Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature.
Augello C; Colombo F; Terrasi A; Trombetta E; Maggioni M; Porretti L; Rossi G; Guerneri S; Silipigni R; Bosari S; Vaira V
Dig Liver Dis; 2018 Jun; 50(6):583-593. PubMed ID: 29673952
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells.
Wang J; Yang X; Ruan B; Dai B; Gao Y; Duan J; Qu S; Tao K; Dou K; Li H
Tumour Biol; 2015 Apr; 36(4):2447-56. PubMed ID: 25412960
[TBL] [Abstract][Full Text] [Related]
32. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.
Hiraga T; Ito S; Nakamura H
Oncol Rep; 2011 Jan; 25(1):289-96. PubMed ID: 21109989
[TBL] [Abstract][Full Text] [Related]
33. STAT3 regulates the migration and invasion of a stem‑like subpopulation through microRNA‑21 and multiple targets in hepatocellular carcinoma.
Zhang N; Duan WD; Leng JJ; Zhou L; Wang X; Xu YZ; Wang XD; Zhang AQ; Dong JH
Oncol Rep; 2015 Mar; 33(3):1493-8. PubMed ID: 25571964
[TBL] [Abstract][Full Text] [Related]
34. A preliminary study of side population cells in human gastric cancer cell line HGC-27.
Gao G; Sun Z; Wenyong L; Dongxia Y; Zhao R; Zhang X
Ann Transplant; 2015 Mar; 20():147-53. PubMed ID: 25773762
[TBL] [Abstract][Full Text] [Related]
35. Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.
Gandhy SU; Imanirad P; Jin UH; Nair V; Hedrick E; Cheng Y; Corton JC; Kim K; Safe S
Oncotarget; 2015 Sep; 6(28):26359-72. PubMed ID: 26317792
[TBL] [Abstract][Full Text] [Related]
36. Aberrantly regulated dysadherin and B-cell lymphoma 2/B-cell lymphoma 2-associated X enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells.
Jiang N; Chen W; Zhang JW; Li Y; Zeng XC; Zhang T; Fu BS; Yi HM; Zhang Q
Mol Med Rep; 2015 Nov; 12(5):7239-46. PubMed ID: 26458963
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
[TBL] [Abstract][Full Text] [Related]
38. Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma.
Wang W; Iyer NG; Tay HT; Wu Y; Lim TK; Zheng L; Song IC; Kwoh CK; Huynh H; Tan PO; Chow PK
BMC Cancer; 2015 Oct; 15():828. PubMed ID: 26520397
[TBL] [Abstract][Full Text] [Related]
39. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
[TBL] [Abstract][Full Text] [Related]
40. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
